Kortuc Inc. Report issue

For profit Phase 1 Phase 2
Founded: Tokyo Japan (2016)

Organization Overview

First Clinical Trial
2019
NCT03946202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Kortuc Inc. | Kortuc, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

hydrogen peroxide (2 trials)

Drugs in Phase 1 Trials (1)

cisplatin (platinol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2